LGALS3 and neoplasm: To determine the impact of C1GalT1 change on galectin-3-mediated tumour cell behaviours, SW620 and HCT116F3 cell-cell interaction and cell adhesion were assessed in the presence of galectin-3 at a pathological concentration similar to that seen in colorectal cancer patients with metastasis [41].